Program Oral Suspension for Large Cats 266 mg

Country: United Kingdom

Bahasa: Inggeris

Sumber: VMD (Veterinary Medicines Directorate)

Bahan aktif:

Lufenuron

Boleh didapati daripada:

Elanco Europe Ltd

Kod ATC:

QP53BC01

INN (Nama Antarabangsa):

Lufenuron

Borang farmaseutikal:

Oral suspension

Jenis preskripsi:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Kumpulan terapeutik:

Cats

Kawasan terapeutik:

Insect Growth Regulator

Status kebenaran:

Expired

Tarikh kebenaran:

1995-05-16

Ciri produk

Revised: January 2016
AN: 01318/2015
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Program Oral Suspension for Large Cats 266 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/ampoule
Lufenuron
266
Excipients
Methyl parahydroxybenzoate
4.56
Propyl parahydroxybenzoate
1.14
For a full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM;
Oral suspension
White aqueous suspension
4.
CLINICAL PARTICULARS:
4.1 TARGET SPECIES
Cats greater than 4.5kg bodyweight
4.2 INDICATIONS FOR USE
For the prevention and lasting control of flea infestation in cats.
Effective
against the dominant flea species _Ctenocephalides felis and C. canis_
4.3 CONTRA-INDICATIONS
None
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5 SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None
Revised: January 2016
AN: 01318/2015
II)
SPECIAL
PRECAUTIONS
TO
BE
TAKEN
BY
THE
PERSON
ADMINISTERING
THE
MEDICINAL PRODUCT TO ANIMALS
Avoid contact with skin and eyes. If contact occurs wash the affected
area
with clean water immediately. Seek medical attention if irritation
persists.
Wash hands after use.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
On very rare occasions, malaise, itching, vomiting or diarrhoea have
been
reported in cats following treatment with Program Suspension.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Can be used during pregnancy and lactation.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
The
minimum
recommended
dose
rate
is
30mg
a.i./kg/month.
This
is
achieved by giving cats over 4.5kg the contents of 1 ampoule
To be fully effective the suspension MUST be administered together
with
food. Shake the ampoule prior to opening. The suspension should be
added
to approximately half of the food ration. The rest of the food should
be
presented when all the dose has been eaten. If several cats are
treated,
ensure that each cat is fed individually. The product can als